Outcome models in clinical studies: Implications for designing and evaluating trials in clinical nutrition

Clinical Nutrition

Volumn 32, Issue 4, 2013, Pages 650-657

  Koller, Michael ^a   Schütz, Tatjana ^b   Valentini, Luzia ^c   Kopp, Ina ^d   Pichard, Claude ^e   Lochs, Herbert ^f   Arends, J ^g   Adolph, M ^h   Bischoff, S C ⁱ   Druml, W ^j   Herbst, B ^k   Koletzko, B ^l   Leischker, A ^m   Ockenga, J ⁿ   Sieber, C ^o   Volkert, D ^o   Weimann, A ^p  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g UNIVERSITY OF FREIBURG   (Germany)

^h UNIVERSITY OF TÜBINGEN   (Germany)

ⁱ UNIVERSITY OF HOHENHEIM   (Germany)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k DGEM Infostelle   (Germany)

^l LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^m Krankenhaus Maria Hilf   (Germany)

ⁿ KLINIKUM BREMEN MITTE   (Germany)

^o UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^p Klinikum St Georg   (Germany)

more..

Author keywords

Clinical nutrition; Clinical practice guidelines; Guideline development; Outcome; Quality of life

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DIET THERAPY; HEALTH CARE COST; HUMAN; INTERVENTION STUDY; MEDICAL DECISION MAKING; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; NUTRITIONAL VALUE; OUTCOME ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; SURVIVAL; VALIDATION PROCESS;

COST-BENEFIT ANALYSIS; DECISION MAKING; ENDPOINT DETERMINATION; HUMANS; MODELS, THEORETICAL; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84879461049     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.08.008     Document Type: Article

References (52)

1. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. ICH harmonized tripartite guideline choice of control group and related issues in clinical trials, E10, 2000. At: [accessed 08.03.11]. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E10/Step4/E10_Guideline.pdf.
2. Lorenz W., Troidl H., Solomkin J.S., Nies C., Sitter H., Koller M., et al. Second step: testing - outcome measurements. World J Surg 1999, 23:768-780.
3. Koller M. Outcome und Lebensqualität. Chirurgie Basisweiterbildung 2007, 583-589. Springer Medizin Verlag, Heidelberg. K.-W. Jauch, W. Mutschler, M.W. Wichmann (Eds.).
4. EMEA Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products 2005, At:, [accessed 08.03.11]. http://www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf.
5. FDA & U.S. Department of Health and Human Services. Guidance for Industry Patient-reported outcome measures: use in medical product development to support labeling claims 2006, At:, [accessed 08.03.11]. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
6. Prentice R.L. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989, 8:431-440.
7. Revicki D., Hayes R.D., Cella D., Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient reported outcomes. JClin Epidemiol 2008, 61:102-109.
8. Baker S.G. Surrogate endpoints: wishful thinking or reality?. JNatl Cancer Inst 2006, 98:502-503.
9. Jaeschke R., Singer J., Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989, 10:407-415.
10. Varadhan K.K., Neal K.R., Dejong C.H., Fearon K.C., Ljungqvist O., Lobo D.N. The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials. Clin Nutr 2010, 29:434-440.
11. Koller M., Lorenz W. Quality of life: a deconstruction for clinicians. JRSM 2002, 95:481-488.
12. Griffiths R.D., Jones C., Palmer T.E.A. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997, 13:295-302.
13. Caro M.M.M., Laviano A., Pichard C. Nutritional interventions and quality of life in adult oncology patients. Clin Nutr 2007, 26:289-301.
14. Avenell A., Handoll H.H. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database Syst Rev 2010, 1:CD001880.
15. Koretz R.L. Death, morbidity and economics are the only end points for trials. Proc Nutr Soc 2005, 64:277-284.
16. American Society of Clinical Oncology Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. JClin Oncol 1996, 14:671-679.
17. Koller M., Neugebauer E.A., Augustin M., Büssing A., Farin E., Klinkhammer-Schalke M., et al. Die Erfassung von Lebensqualität in der Versorgungsforschung- konzeptuelle, methodische und strukturelle Voraussetzungen (Memorandum III: Methoden der Versorgungsforschung). Gesundheitswesen 2009, 71:864-872.
18. Klinkhammer-Schalke M., Koller M., Ehret C., Steinger B., Ernst B., Wyatt J.C., et al. Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT. Br J Cancer 2008, 99:415-422.
19. Fayers P.M., Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes 2007, John Wiley, Chichester. 2nd ed.
20. Koller M., Aaronson N.K., Blazeby J., Bottomley A., Dewolf L., Fayers P., et al. Translation procedures for standardised quality of life questionnaires: the European organisation for research and treatment of cancer (EORTC) approach. Eur J Cancer 2007, 43:1810-1820. on behalf of the EORTC Quality of Life Group.
21. Kuliś D., Arnott M., Greimel E.R., Bottomley A., Koller M. Trends in translation requests and arising issues regarding cultural adaptation. Expert Rev Pharmacoecon Outcome Res 2011, 11:307-314. on behalf of the EORTC QLG.
22. Baxter J.P., Fayers P.M., McKinlay A.W. The clinical and psychometric validation of a questionnaire to assess the quality of life of adult patients treated with long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 2010, 34:131-142.
23. Beattie A.H., Prach A.T., Baxter J.P., Pennington C.R. Arandomized controlled trial evaluating the use of enteral nutritional supplements postoperatively in malnourished surgical patients. Gut 2000, 46:813-818.
24. Tillinger W., Mittermaier C., Lochs H., Moser G. Health-related quality of life in patients with Crohn's disease: influence of surgical operation-a prospective trial. Dig Dis Sci 1999, 44:932-938.
25. Müller M., Lohmann S., Thul P., Weimann A., Grill E. Functioning and health in patients with cancer on home parenteral nutrition: a qualitative study. Health Qual Life Outcomes 2010, 8:41.
26. Rychlik R. Strategies in pharmacoeconomics and outcome research 2002, Haworth Press Inc, New York, London, Oxford.
27. Soloniuk L., McPeek B. Do the pluses outweigh the minuses? A quality checklist for cost-analysis studies in anesthesia and surgery. Theor Surg 1988, 2:209-214.
28. Menne R., Adolph M., Brock E., Schneider H., Senkal M. Cost analysis of parenteral nutrition regimens in the intensive care unit: three-compartment bag system vs multibottle system. JPEN J Parenter Enteral Nutr 2008, 32:606-612.
29. Gianotti L., Braga M., Frei A., Greiner R., Di Carlo V. Health care resources consumed to treat postoperative infections. Cost saving by perioperative immunonutrition. Shock 2000, 14:325-330.
30. Jenicek M. Epidemiology. The logic of modern medicine 1995, Epimed, Montreal.
31. Ratcliffe J., Brazier J.E., Campbell W.B., Palfreyman S., MacIntyre J.B., Michaels J.A. Cost-effectiveness analysis of surgery versus conservative treatment for uncomplicated varicose veins in a randomized clinical trial. Br J Surg 2006, 93:182-186.
32. Norman K., Pirlich M., Smoliner C., Kilbert A., Schulzke J.D., Ockenga J., et al. Cost-effectiveness of a 3-month intervention with oral nutritional supplements in disease-related malnutrition: a randomised controlled pilot study. Eur J Clin Nutr 2011, 65:735-742.
33. Weinstein M.C., Fineberg H.V. Clinical decision analysis 1980, Saunders, Philadelphia.
34. Ottery F.D. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996, 12:S15-S19.
35. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al. Frailty in older adults: evidence for a phenotype. JGerontol 2001, 56A:M146-M151.
36. Best W.R., Becktel J.M., Singleton J.W. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979, 77:843-846.
37. van den Broek M.A., van Dam R.M., van Breukelen G.J., Bemelmans M.H., Oussoultzoglou E., Pessaux P., et al. Development of a composite endpoint for randomized controlled trials in liver surgery. Br J Surg 2011, 98:1138-1145.
38. Kunz R., Burnand B., Schünemann H.J. Grading of recommendations, assessment, development and evaluation (GRADE) working group. [The GRADE system. An international approach to standardize the graduation of evidence and recommendations in guidelines]. Internist 2008, 49:673-680.
39. Guyatt G.H., Oxman A.D., Kunz R., Atkins D., Brozek J., Vist G., et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. JClin Epidemiol 2011, 64:395-400.
40. Scottish Intercollegiate Guidelines Network SIGN guidelines - an introduction to SIGN methodology for the development of evidence-based guidelines 1999, SIGN publication No. 39, SIGN secretariat, Royal College of Physicians of Edinburgh, Edinburgh.
41. Agency for Health Care Policy and Research Clinical practice guideline no. 1 1993, AHCPR Publication No. 92-0023.
42. Häuser W., Gold J., Stallmach A., Caspary W.E., Stein J. Development and validation of the celiac disease questionnaire (CDQ), a disease-specific health-related quality of life measure for adult patients with celiac disease. JClin Gastroenterol 2007, 41:157-166.
43. Younussi Z.M., Guyatt G., Kiwi M., Boparai N., King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999, 45:295-300.
44. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNatl Cancer Inst 1993, 85:365-376. http://groups.eortc.be/qol/.
45. Brucker P.S., Yost K., Cashy J., Webster K., Cella D. General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G). Eval Health Prof 2005, 28:192-211. http://www.facit.org.
46. Eypasch E., Williams J.I., Wood-Dauphinee S., Ure B.M., Schmülling C., Neugebauer E., et al. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg 1995, 82:216-222.
47. Pallis A.G., Mouzas I.A., Vlachonikolis I.G. The inflammatory bowel disease questionnaire. A review of its national validation studies. Inflamm Bowel Dis 2004, 10:261-269.
48. Patrick D.L., Drossmann D.A., Frederick I.O., Dicesare J., Puder K.L. Quality of life in persons with irritable bowel syndrome. Development and validation of a new measure. Dig Dis Sci 1998, 43:400-411.
49. Ware J.E., Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. JClin Epidemiol 1998, 51:903-912. http://www.sf-36.org.
50. Skevington S.M., Lofty M., O'Connell K.A. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004, 13:299-310. http://www.rand.org.
51. Volkert D., Berner Y.N., Berry E., Cederholm T., Coti Bertrand P., Milne A., et al. ESPEN guidelines on enteral nutrition: Geriatrics. Clin Nutr 2006, 25:330-360.
52. Pittiruti M., Hamilton H., Biffi R., MacFie J., Pertkiewicz M. ESPEN guidelines on parenteral nutrition: Central Venous Catheters (access, care, diagnosis and therapy of complications). Clin Nutr 2009, 28:365-377.